microcystin and naringin

Gastropods are an important food source for aquatic animals, and have been demonstrated to transfer microcystin (MC) to higher trophic levels through the food web. In this study, we performed an oral administration experiment to evaluate whether naringin can inhibit MC-LR uptake in the freshwater snail Sinotaia histrica. We also observed the effect of MC-LR on the organizational pathology of the hepatopancreas in S. histrica. Following exposure to cells of Microcystis ichthyoblabe, S. histrica showed vacuolization and separation of the basal lamina from cells in the hepatopancreas. Initial treatment with 1mM naringin resulted in the prevention of MC-LR uptake rate by approximately 60% over 8days, whereas initial treatment with 10mM naringin suppressed microcystin uptake in 2days, despite an increase in MC-LR levels in the snail from days 5 to 8. With continuous treatment of 10mM naringin, the uptake prevention rate was 100%. Overall, we observed a strong inhibitory effect against MC-LR with naringin treatment. This study provides a potential mechanism to prevent the uptake of microcystin in the aquatic food web, thereby limiting its toxicity in cyanobacterial bloom-polluted areas where the environment can be controlled and may have further applications in the aquaculture of gastropods.

Topics: Animals; Bacterial Toxins; Environmental Monitoring; Flavanones; Fresh Water; Hepatopancreas; Microcystins; Microcystis; Snails

The protein phosphatase inhibitor microcystin-LR (MC) induced hepatocyte apoptosis mediated by the calcium-calmodulin-dependent multifunctional protein kinase II (CaMKII). CaMKII antagonists were added at various times after MC to define for how long the cells depended on CaMKII activity to be committed to execute the various parameters of death. Shrinkage and nonpolarized budding were reversible and not coupled to commitment. A critical commitment step was observed 15-20 min after MC (0.5 microM) addition. After this, CaMKII inhibitors no longer protected against polarized budding, DNA fragmentation, lost protein synthesis capability, and cell disruption. Commitment to chromatin hypercondensation occurred 40 min after MC addition. In conclusion, irreversible death commitment was coupled to polarized budding, but not to shrinkage or chromatin condensation. Antioxidant prevented chromatin condensation when given after the CaMKII-dependent commitment point, suggesting that CaMKII had mediated the accumulation of a second messenger of reactive oxygen species nature.

Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Caspase Inhibitors; Caspases; Cell Size; Cell Survival; Cells, Cultured; Chromatin; DNA Fragmentation; Dose-Response Relationship, Drug; Flavanones; Hepatocytes; Male; Microcystins; Microscopy, Electron, Transmission; Models, Biological; Peptides, Cyclic; Phosphorylation; Rats; Rats, Wistar; Time Factors

Autophagic activity in isolated rat hepatocytes is strongly suppressed by OA (okadaic acid) and other PP (protein phosphatase)-inhibitory toxins as well as by AICAR (5-aminoimidazole-4-carboxamide riboside), a direct activator of AMPK (AMP-activated protein kinase). To investigate whether AMPK is a mediator of the effects of the toxin, a phosphospecific antibody directed against the activation of phosphorylation of the AMPK alpha (catalytic)-subunit at Thr172 was used to assess the activation status of this enzyme. AICAR as well as all the toxins tested (OA, microcystin-LR, calyculin A, cantharidin and tautomycin) induced strong, dose-dependent AMPKalpha phosphorylation, correlating with AMPK activity in situ (in intact hepatocytes) as measured by the AMPK-dependent phosphorylation of acetyl-CoA carboxylase at Ser79. All treatments induced the appearance of multiple, phosphatase-sensitive, low-mobility forms of the AMPK alpha-subunit, consistent with phosphorylation at several sites other than Thr172. The flavonoid naringin, an effective antagonist of OA-induced autophagy suppression, inhibited the AMPK phosphorylation and mobility shifting induced by AICAR, OA or microcystin, but not the changes induced by calyculin A or cantharidin. AMPK may thus be activated both by a naringin-sensitive and a naringin-resistant mechanism, probably involving the PPs PP2A and PP1 respectively. Neither the Thr172-phosphorylating protein kinase LKB1 nor the Thr172-dephosphorylating PP, PP2C, were mobility-shifted after treatment with toxins or AICAR, whereas a slight mobility shifting of the regulatory AMPK beta-subunit was indicated. Immunoblotting with a phosphospecific antibody against pSer108 at the beta-subunit revealed a naringin-sensitive phosphorylation induced by OA, microcystin and AICAR and a naringin-resistant phosphorylation induced by calyculin A and cantharidin, suggesting that beta-subunit phosphorylation could play a role in AMPK activation. Naringin antagonized the autophagy-suppressive effects of AICAR and OA, but not the autophagy suppression caused by cantharidin, consistent with AMPK-mediated inhibition of autophagy by toxins as well as by AICAR.

Topics: Amino Acids; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Autophagy; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; Flavanones; Male; Microcystins; Multienzyme Complexes; Okadaic Acid; Peptides, Cyclic; Phosphorylation; Protein Serine-Threonine Kinases; Protein Subunits; Rats; Rats, Wistar; Ribonucleotides; Toxins, Biological